Assessment of nucleotide-based drug strategies targeting the estrogen receptor as potential breast cancer therapeutics
Williard, R.; Benz, C.; Kushner, P.; Hunt, C.A.; Scott, G.; Webb, P.
Pharmaceutical Research (New York) 10(10 Suppl): S94
1993
ISSN/ISBN: 0724-8741 Accession: 030197766
PDF emailed within 1 workday: $29.90
Related References
Hu, S.; Yin, F.; Nie, L.; Wang, Y.; Qin, J.; Chen, J. 2022: Estrogen and Estrogen Receptor Modulators: Potential Therapeutic Strategies for COVID-19 and Breast Cancer Frontiers in Endocrinology 13: 829879Kumar, N.; Gulati, H.K.; Sharma, A.; Heer, S.; Jassal, A.K.; Arora, L.; Kaur, S.; Singh, A.; Bhagat, K.; Kaur, A.; Singh, H.; Singh, J.V.; Bedi, P.M.S. 2021: Most recent strategies targeting estrogen receptor alpha for the treatment of breast cancer Molecular Diversity 25(1): 603-624
Amaral, C.; Augusto, T.V.; Almada, M.; Cunha, S.C.; Correia-da-Silva, G.; Teixeira, N.ér. 2020: The potential clinical benefit of targeting androgen receptor (AR) in estrogen-receptor positive breast cancer cells treated with Exemestane Biochimica et Biophysica Acta. Molecular Basis of Disease 1866(5): 165661
Rasel, M.S.I.; Mohona, F.A.; Akter, W.; Kabir, S.; Chowdhury, A.A.; Chowdhury, J.A.; Hassan, M.A.; Al Mamun, A.; Ghose, D.K.; Ahmad, Z.; Khan, F.S.; Bari, M.F.; Rahman, M.S.; Amran, M.S. 2022: Exploration of Site-Specific Drug Targeting-A Review on EPR-, Stimuli-, Chemical-, and Receptor-Based Approaches as Potential Drug Targeting Methods in Cancer Treatment Journal of Oncology 2022: 9396760
Shee, K.; Yang, W.; Hinds, J.W.; Hampsch, R.A.; Varn, F.S.; Traphagen, N.A.; Patel, K.; Cheng, C.; Jenkins, N.P.; Kettenbach, A.N.; Demidenko, E.; Owens, P.; Faber, A.C.; Golub, T.R.; Straussman, R.; Miller, T.W. 2018: Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer Journal of Experimental Medicine 215(3): 895-910
Falagan-Lotsch, P.; Grzincic, E.M.; Murphy, C.J. 2017: New Advances in Nanotechnology-Based Diagnosis and Therapeutics for Breast Cancer: An Assessment of Active-Targeting Inorganic Nanoplatforms Bioconjugate Chemistry 28(1): 135-152
Ali, M.A.; Farah, M.A.; Al-Anazi, K.M.; Basha, S.H.; Bai, F.; Lee, J.; Al-Hemaid, F.M.A.; Mahmoud, A.H.; Hailan, W.A.Q. 2020: In Silico Elucidation of the Plausible Inhibitory Potential of Withaferin a of Withania Somnifera Medicinal Herb Against Breast Cancer Targeting Estrogen Receptor Current Pharmaceutical Biotechnology 21(9): 842-851
Bouricha, E.Mehdi.; Hakmi, M.; Akachar, J.; Zouaidia, F.; Ibrahimi, A. 2021: In-silico identification of potential inhibitors targeting the DNA binding domain of estrogen receptor α for the treatment of hormone therapy-resistant breast cancer Journal of Biomolecular Structure and Dynamics 2021: 1-8
Chatterjee, P.; Karn, R.; Emerson, I.A.; Banerjee, S. 2023: Docking and Molecular Dynamics Simulation Revealed the Potential Inhibitory Activity of Amygdalin in Triple-Negative Breast Cancer Therapeutics Targeting the BRCT Domain of BARD1 Receptor Molecular Biotechnology 2023
Dai, Y.-H.; Chen, G.-Y.; Tang, C.-H.; Huang, W.-C.; Yang, J.-C.; Wu, Y.-C. 2021: Drug Screening of Potential Multiple Target Inhibitors for Estrogen Receptor-α-positive Breast Cancer In Vivo 35(2): 761-777
Dekker, T.J.A.; ter Borg, S.; Hooijer, G.K.J.; Meijer, S.L.; Wesseling, J.; Boers, J.E.; Schuuring, E.; Bart, J.; van Gorp, J.; Bult, P.; Riemersma, S.A.; van Deurzen, C.H.M.; Sleddens, H.F.B.M.; Mesker, W.E.; Kroep, J.R.; Smit, V.T.H.B.M.; van de Vijver, M.J. 2015: Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach Breast Cancer Research and Treatment 152(2): 247-252
Sirianni, R.; Zolea, F.; Chimento, A.; Ruggiero, C.; Cerquetti, L.; Fallo, F.; Pilon, C.; Arnaldi, G.; Carpinelli, G.; Stigliano, A.; Pezzi, V. 2012: Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment Journal of clinical endocrinology and metabolism 97(12): E2238-E2250
Tandon, M.; Vemula, S.V.; Mittal, S.K. 2011: Emerging strategies for EphA2 receptor targeting for cancer therapeutics Expert Opinion on Therapeutic Targets 15(1): 31-51
Alhadrami, H.A.; Sayed, A.M.; Melebari, S.A.; Khogeer, A.A.; Abdulaal, W.H.; Al-Fageeh, M.B.; Algahtani, M.; Rateb, M.E. 2021: Targeting allosteric sites of human aromatase: a comprehensive in-silico and in-vitro workflow to find potential plant-based anti-breast cancer therapeutics Journal of Enzyme Inhibition and Medicinal Chemistry 36(1): 1334-1345
Renoir, J.-M.; Marsaud, V.ér.; Lazennec, G. 2013: Estrogen receptor signaling as a target for novel breast cancer therapeutics Biochemical Pharmacology 85(4): 449-465
Olayoku, F.R.; Verhoog, N.J.D.; Louw, A. 2023: Cyclopia extracts act as selective estrogen receptor subtype downregulators in estrogen receptor positive breast cancer cell lines: Comparison to standard of care breast cancer endocrine therapies and a selective estrogen receptor agonist and antagonist Frontiers in Pharmacology 14: 1122031
Groenendijk, F.H.; Zwart, W.; Floore, A.; Akbari, S.; Bernards, R. 2013: Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnostics Breast Cancer Research and Treatment 140(3): 475-484
Welsh, J. 1997: Vitamin D compounds as potential therapeutics for estrogen-independent breast cancer Nutrition 13(10): 915-917
Oliveira, M.C.; Neto, C.; Gano, L.; Marques, F.; Santos, I.; Thiemann, T.; Santos, A.C.; Botelho, F.; Oliveira, C.F. 2012: Estrogen receptor ligands for targeting breast tumours: a brief outlook on radioiodination strategies Current Radiopharmaceuticals 5(2): 124-141
Han, L.; Liu, B.; Jiang, L.; Liu, J.; Han, S. 2016: MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(10): 13205-13214